MedPath

i-Tack N POWERED MESH FIXATION

Not Applicable
Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2025/04/085602
Lead Sponsor
Meril Life Sciences Pvt Ltd
Brief Summary

Title: A prospective, single-arm, open-label, multi-center, observational, Post- Marketing Clinical Surveillance Study to evaluate the safety and performance of i- Tack™ N in subject intended for surgical mesh fixation to soft tissue in various open or laparoscopic surgical procedures.



Short Title: i-Tack N POWERED MESH FIXATION



Protocol ID, Version & Date: i-Tack N POWERED MESH FIXATION\_Version\_1.0.0\_12-Dec-2024



Study device: i-Tack(TM) N (Sterile Non-absorbable Powered Mesh Fixation Device)



Indication: i-Tack(TM) N is intended for the fixation of surgical mesh to soft tissue in various minimally invasive and open general surgical and laparoscopic procedures, such as hernia repair.



Objective: This study aims to evaluate the safety and performance of i-Tack(TM) N



Study Design: A prospective, single-arm, open-label, multi-center, observational, Post Marketing Clinical Surveillance Study.



Rationale of the study: Mesh fixation devices are of fundamental importance in surgical outcomes. Hence, the present study is to evaluate the safety and performance of a sterile, non-absorbable powered mesh fixation device composed of the delivery system and titanium spikes (i-Tack™ N mesh fixation device) in the fixation of surgical mesh to soft tissue in various minimally invasive and open general surgical and laparoscopic procedures, such as hernia repair. The device is sterilized by ethylene oxide.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria
  • 1.All consecutive Subjects who will underwent surgical experience like soft tissue in various minimally invasive and open general surgical and laparoscopic procedures, such as hernia repair.
  • The subject must be an adult age group, and both men and women are included in the study.
  • The Subjects should be treated with i-Tack™ N.
  • The Subjects must be willing and able to provide written Informed Consent by signing and dating the IRB or EC-approved Informed Consent form.
  • A minimum of 4 mm thickness of tissue over underlying bone, vessels, or viscera is required for applying i-Tack™ N.
Exclusion Criteria
  • i-Tack™ N is not recommended where an extended approximation of tissues under stress is required.
  • i-Tack™ N should not be used in tissues that have a direct anatomic relationship to major vascular structures.
  • i-Tack™ N should not be used in Subjects who underwent ischemic or necrotic tissue surgery.
  • i-Tack™ N should not be used in Subjects whose tissue cannot be inspected visually for hemostasis.
  • Subjects (female) who are pregnant or actively breast feeding.
  • Subjects with specific drug allergies or past comorbidities 7.
  • Subjects with a complicated hernia and Subject unfit for general anesthesia.

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
2.Complications1.Time Frame: 7 days ± 2 days, 6 months ± 30 days | 2.Time Frame: Intra-operative, 7 days ± 2 days, 30 days ± 5 days, 3 months ± 15 days, 6 months ± 30 days, 1 year± 30 days, 3 year± 30 days and 5 year± 30 days
1.Re-occurrence rate of hernia1.Time Frame: 7 days ± 2 days, 6 months ± 30 days | 2.Time Frame: Intra-operative, 7 days ± 2 days, 30 days ± 5 days, 3 months ± 15 days, 6 months ± 30 days, 1 year± 30 days, 3 year± 30 days and 5 year± 30 days
Secondary Outcome Measures
NameTimeMethod
1.Re-occurrence rate of hernia2.Post-operative pain

Trial Locations

Locations (1)

Shri Shreeji Hospital and Advance Laparoscopic Surgery Center

🇮🇳

Valsad, GUJARAT, India

Shri Shreeji Hospital and Advance Laparoscopic Surgery Center
🇮🇳Valsad, GUJARAT, India
Dr Rajesh Shrivastava
Principal investigator
9925029477
dr.rajeshshree70@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.